title: The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.
abstract: Proper regulation of cell cycle progression is pivotal for maintaining genome stability. In a search for DNA damage-inducible, CHK1-modulated genes, we have identified BTG3 (B-cell translocation gene 3) as a direct p53 target. The p53 transcription factor binds to a consensus sequence located in intron 2 of the gene both in vitro and in vivo, and depletion of p53 by small interfering RNA (siRNA) abolishes DNA damage-induced expression of the gene. Furthermore, ablation of BTG3 by siRNA in cancer cells results in accelerated exit from the DNA damage-induced G2/M block. In vitro, BTG3 binds to and inhibits E2F1 through an N-terminal domain including the conserved box A. Deletion of the interaction domain in BTG3 abrogates not only its growth suppression activity, but also its repression on E2F1-mediated transactivation. We also present evidence that by disrupting the DNA binding activity of E2F1, BTG3 participates in the regulation of E2F1 target gene expression. Therefore, our studies have revealed a previously unidentified pathway through which the activity of E2F1 may be guarded by activated p53.
authors: Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
authors: Yi-Hung
authors: YH
authors: Ou
authors: Pei-Han
authors: PH
authors: Chung
authors: Fu-Fei
authors: FF
authors: Hsu
authors: Te-Ping
authors: TP
authors: Sun
authors: Wen-Ying
authors: WY
authors: Chang
authors: Sheau-Yann
authors: SY
authors: Shieh
mesh_terms: D018797:Cell Cycle Proteins; D045744:Cell Line, Tumor; D004249:DNA Damage; D050687:E2F1 Transcription Factor / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006801:Humans; D007438:Introns; D020411:Oligonucleotide Array Sequence Analysis; D011485:Protein Binding; D011506:Proteins / Q000235:genetics / Q000378:metabolism*; D015533:Transcriptional Activation; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*
chemical_list: C424522:BTG3 protein, human; D018797:Cell Cycle Proteins; D050687:E2F1 Transcription Factor; C493753:E2F1 protein, human; D011506:Proteins; D016159:Tumor Suppressor Protein p53
references: Mol Cell Biol. 2000 Mar;20(5):1797-815
references: 10669755
references: EMBO J. 2000 Feb 15;19(4):662-71
references: 10675335
references: Genes Dev. 2001 Feb 1;15(3):267-85
references: 11159908
references: Lab Invest. 2001 Feb;81(2):217-29
references: 11232644
references: Br J Cancer. 2001 Mar 23;84(6):754-9
references: 11259088
references: FEBS Lett. 2001 May 25;497(2-3):67-72
references: 11377414
references: Genes Dev. 2001 Jul 15;15(14):1833-44
references: 11459832
references: Hum Mutat. 2002 Jun;19(6):607-14
references: 12007217
references: Cell Death Differ. 2003 Apr;10(4):431-42
references: 12719720
references: Nat Cell Biol. 2003 May;5(5):401-9
references: 12717439
references: Nat Cell Biol. 2003 Jun;5(6):552-8
references: 12766778
references: Trends Biochem Sci. 2004 Aug;29(8):409-17
references: 15362224
references: Nat Rev Cancer. 2004 Oct;4(10):793-805
references: 15510160
references: J Biol Chem. 1991 Mar 25;266(9):5401-6
references: 2005087
references: Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3353-7
references: 1849653
references: Genes Chromosomes Cancer. 1991 Jan;3(1):24-36
references: 2069907
references: J Biol Chem. 1991 Aug 5;266(22):14511-8
references: 1713584
references: EMBO J. 1992 Apr;11(4):1663-70
references: 1373383
references: Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12146-50
references: 8618861
references: Cell. 1996 May 17;85(4):537-48
references: 8653789
references: Cell. 1996 May 17;85(4):549-61
references: 8653790
references: Cell Growth Differ. 1996 Oct;7(10):1327-36
references: 8891336
references: Science. 2006 Feb 24;311(5764):1141-6
references: 16497931
references: Cell Death Differ. 2006 Jun;13(6):951-61
references: 16575405
references: Cell Death Differ. 2006 Jun;13(6):941-50
references: 16601750
references: Mol Cell. 2006 Aug 4;23(3):331-41
references: 16885023
references: Nat Genet. 1996 Dec;14(4):482-6
references: 8944033
references: Leukemia. 1997 Mar;11(3):370-5
references: 9067576
references: Mol Cell Biol. 1998 Jun;18(6):3212-22
references: 9584162
references: Oncogene. 1998 May;16(20):2687-93
references: 9632145
references: Exp Cell Res. 1999 Jun 15;249(2):337-48
references: 10366433
references: Oncogene. 1999 Sep 23;18(39):5381-92
references: 10498892
references: J Biol Chem. 2005 Mar 4;280(9):7748-57
references: 15618221
references: Mol Biol Cell. 2005 Apr;16(4):1684-95
references: 15659650
references: Oncogene. 2005 Apr 18;24(17):2810-26
references: 15838517
references: Oncogene. 2005 Apr 18;24(17):2899-908
references: 15838523
references: Genes Dev. 2005 Jun 15;19(12):1485-95
references: 15964998
references: EMBO J. 2005 Nov 2;24(21):3724-36
references: 16211008
references: Genes Dev. 2006 Jan 15;20(2):236-52
references: 16418486
references: J Cell Sci. 2006 Feb 15;119(Pt 4):646-58
references: 16434477
references: J Biol Chem. 2006 Feb 17;281(7):3800-9
references: 16316983